Progestin alone as primary treatment of endometrial carcinoma in premenopausal women: Report of seven cases and review of the literature

Cancer

Volumn 79, Issue 2, 1997, Pages 320-327

  Kim, Young B ^a   Holschneider, Christine H ^a   Ghosh, Kris ^a   Nieberg, Roberta K ^b   Montz, Fredrick J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

anovulation; endometrial carcinoma; infertility; polycystic ovary syndrome; progestin; uterine neoplasms

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE; GESTAGEN; HYDROXYPROGESTERONE CAPROATE; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; MESTRANOL; NORETHISTERONE; ORAL CONTRACEPTIVE AGENT;

ABDOMINAL HYSTERECTOMY; ADOLESCENT; ADULT; ARTICLE; CANCER HORMONE THERAPY; CLINICAL ARTICLE; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; FEMALE; FEMALE FERTILITY; HUMAN; HUMAN TISSUE; LAPAROTOMY; OVARY POLYCYSTIC DISEASE; PATIENT SELECTION; PREGNANCY; PREMENOPAUSE; PRIORITY JOURNAL; RECURRENT CANCER;

ADENOCARCINOMA; ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MEGESTROL ACETATE; PREMENOPAUSE; TREATMENT OUTCOME;

EID: 0031024369     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970115)79:2<320::AID-CNCR15>3.0.CO;2-2     Document Type: Article

References (38)

1. Dockerty MB, Lovelady SB, Foust GT Jr. Carcinoma of the corpus uteri in young women. Am J Obstet Gynecol 1951; 61:966-81.
2. McGee WB. Carcinoma of the endometrium in women under forty years of age. Obstet Gynecol 1958; 11:388-90.
3. Crissman JD, Azoury RS, Barnes AE, Schellhas HF. Endometrial carcinoma in women 40 years of age or younger. Obstet Gynecol 1981;57:699-704.
4. Ostor AG, Adam R, Gutteridge BH, Fortune DW. Endometrial carcinoma in young women. Aust N Z J Obstet Gynaecol 1982;22:38-42.
5. Gallup DG, Stock RJ. Adenocarcinoma of the endometrium in women 40 years of age or younger. Obstet Gynecol 1984; 64:417-9.
6. Jackson RL, Dockerty MB. The Stein-Leventhal syndrome:analysis of 43 cases with special reference to association with endometrial carcinoma. Am J Obstet Gynecol 1957; 73:161-73.
7. Andrews WC, Andrews MC. Stein-Leventhal syndrome with associated adenocarcinoma of the endometrium. Am J Obstet Gynecol 1960;80:632-6.
8. Tsoutsoplides GC. Endometrial adenocarcinoma and the Stein-Leventhal syndrome. Am J Obstet Gynecol 1983; 147:844-5.
9. Cheon HK. Prognosis of endometrial carcinoma. Obstet Gynecol 1969;34:680-4.
10. Geisler HE, Huber CP, Rogers S. Carcinoma of the endometrium in premenopausal women. Am J Obstet Gynecol 1969; 104:657-63.
11. Silverberg SG, Makowski EL, Roche WD. Endometrial cancer in women under 40 years of age. Cancer 1977;39:592-8.
12. Frick HC, Murrell EW, Richart RM, Berger AP, Lawry MF. Carcinoma of the endometrium. Am J Obstet Gynecol 1973;115:663-76.
13. Connolly PJ, Alberhaskey RC, Christopherson WB. Carcinoma of the endometrium III:analysis of 865 cases of adenocarcinoma and adenoacanthoma. Obstet Gynecol 1982; 59:569-75.
14. Quinn MA, Kneale BJ, Fortune DW. Endometrial cancer in premenopausal women:a clinicopathological study. Gynecol Oncol 1983;20:298-306.
15. Hacker NF. Uterine cancer. In: Berek JS, Hacker NF, editors. Practical gynecologic oncology. 2nd edition. Baltimore:Williams and Wilkins, 1994:285-326.
16. Kempson RL, Pokorny GE. Adenocarcinoma of the endometrium in women aged 40 and younger. Cancer 1968;21:650-62.
17. O'Neill RT. Pregnancy following hormonal therapy for adenocarcinoma of the endometrium. Am J Obstet Gynecol 1970;108:318-21.
18. Fechner RE, Kaufman RH. Endometrial adenocarcinoma in Stein-Leventhai syndrome. Cancer 1974;34:444-52.
19. Greenblatt RB, Gambrell RD, Stoddard LD. The protective role of progesterone in the prevention of endometrial carcinoma. Pathol Res Pract 1982; 174:297-318.
20. Bokhman JV, Chepick OF, Volkova AT, Vishnevsky AS. Can primary endometrial carcinoma stage I be cured without surgery and radiation therapy? Gynecol Oncol 1985;20:139-55.
21. Farhi DC, Nosanchuk J, Sliverberg SG. Endometrial adenocarcinoma in women under 25 years of age. Obstet Gynecol 1986;68:741-5.
22. Lee KR, Scully RE. Complex endometrial hyperplasia and carcinoma in adolescents and young women 15 to 20 years of age:a report of 10 cases. Int J Gynecol Pathol 1989; 8:201-13.
23. Kimmig R, Strowitzki T, Muller-Hocker J, Kurzl R, Korell M, Hepp H. Conservative treatment of endometrial cancer permitting subsequent triplet pregnancy. Gynecol Oncol 1995;58:255-7.
24. Kurman RJ, Norris HJ. Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Cancer 1982;49:2547-59.
25. International Federation of Gynecology and Obstetrics. Annual report on the results of treatment in gynecologic cancer. Int J Gynaecol Obstet 1989;28:189-90.
26. Ferenczy A, Gelfand MM. The biologic significance of cytologic atypia in progestin-treated endometrial hyperplasia. Am J Obstet Gynecol 1989; 160:126-31.
27. Gal D, Edman CD, Vellios F. Long-term effect of megestrol acetate in the treatment of endometrial hyperplasia. Am J Obstet Gynecol 1983; 146:316-22.
28. Kurman RJ, Kaminski PF, Norris HJ. The behavior of endometrial hyperplasia: a long term study of "untreated" hyperplasia in 170 patients. Cancer 1985;56:403-12.
29. Ferenczy A, Gelfand MM, Tzipris F. The cytodynamics of endometrial hyperplasia and carcinoma:a review. Ann Pathol 1983;3:189-201.
30. Kelley RM, Baker WH. Progestational agents in the treatment of carcinoma of the endometrium. N Engl J Med 1961; 264:216-22.
31. Podratz KC, O'Brien PC, Malkasian GD, Decker DG, Jefferies JA, Edmonson JH, et al. Effects of progestational agents in treatment of endometrial carcinoma. Obstet Gynecol 1985;66:106-10.
32. Shanklin DR. Endometrial carcinoma:diagnostic criteria, pathogenesis, natural history, and associations. Pathol Annu 1978;13:233-87.
33. Novak ER, Woodruff JD. "Hyperplasia of the endometrium." In: Gynecologic and obstetric pathology with clinical and endocrine relations. 8th edition. Philadelphia:W.B. Saunders, 1979: 2196-8.
34. Larson DM, Johnson KK, Broste SK, Krawisz BR, Kresl JJ. Comparison of D+C and office endometrial biopsy in predicting final histopathologic grade in endometrial cancer. Obstet Gynecol 1995;86:38-42.
35. Kim SH, Kim HD, Song YS, Kang SB, Lee HP. Detection of deep myometrial invasion in endometrial carcinoma. J Comput Assist Tomogr 1995; 19:766-72.
36. Yamashita Y, Mizutani H, Torashima M, Takahashi M, Miyazaki K, Okamura H, et al. Assessment of myometrial invasion in endometrial carcinoma:transvaginal sonography vs. contrast-enhanced MR imaging. AJR Am J Roentgenol 1993; 161:595-9.
37. Hricak H, Stern JL, Fisher MR, Shapeero LG, Winkler ML, Lacey CG. Endometrial carcinoma staging by MR imaging. Radiology 1987; 162:297-305.
38. Scambia G, Gadducci A, Benedetti-Panici P, Foti E, Ferdeghini M, Ferrandina G, et al. Combined use of CA 125 and CA 15-3 in patients with endometrial carcinoma. Gynecol Oncol 1994;54:292-7.